Indian J Pharm Close
 

Figure 3: Median expression levels of BCL-2 transcript in the peripheral blood cells of breast cancer (BC) patients and healthy controls. Calculations were performed as explained in Figure 1. Significant differences were found in the levels of BCL-2 expression between total, nonmetastatic, early-stage (I, II), and low-grade BC patients and normal controls (P = 0.0045, P = 0.0157, P = 0.0025, and P = 0.0248, respectively)

Figure 3: Median expression levels of BCL-2 transcript in the peripheral blood cells of breast cancer (BC) patients and healthy controls. Calculations were performed as explained in Figure 1. Significant differences were found in the levels of BCL-2 expression between total, nonmetastatic, early-stage (I, II), and low-grade BC patients and normal controls (P = 0.0045, P = 0.0157, P = 0.0025, and P = 0.0248, respectively)